xxx
 
Print This Page
Share this page: More
 

Skull Base Chondrosarcoma

What is a chondrosarcoma?

Chondrosarcoma is a malignant bone cancer that mainly affects cartilage. It can begin in cells in the thighbone, arm, pelvis, knee and spine. It may also start in the skull base.

The second most common type of bone cancer, chondrosarcoma occurs most often in people between the ages of 50 and 70. It generally grows slowly, but sometimes develops more rapidly and is likely to spread.

Symptoms of chondrosarcoma:

The following are the most common symptoms of chondrosarcoma. However, each individual may experience symptoms differently.

Symptoms may include any of the following:

  • headache
  • unusual visual changes or problems
  • tinnitus (ringing in the ears)

Diagnosis of chondrosarcoma:

In addition to a complete medical history and physical examination, diagnostic procedures for chondroma may include X-ray, CT scan or MRI to determine the size and location of the tumor. Learn more about diagnosing skull base tumors.

Treatment for chondrosarcoma:

Surgery is the most common treatment for chondrosarcoma. Radiation therapy may be performed after surgery. Learn more about treatment for skull base tumors.

To make an appointment or request a consultation, contact the Johns Hopkins Skull Base Tumor Center at 410-614-0585.

 

Ranked #1 Neurology & Neurosurgery in the US

US News and World Report Best HospitalsJohns Hopkins Hospital has earned the top spot in US News News & World Report's annual rankings of American hospitals — for the 21st year in a row. Johns Hopkins Neurology and Neurosurgery is also ranked #1 in the nation.

Related Links

Chordoma: Drug screening starts to find new treatment for rare bone cancer
The Chordoma Foundation has awarded a $200,000 grant to Dr. Gary Gallia, a skull-base neurosurgeon and cancer biologist at Johns Hopkins. Gallia’s focus is on developing new therapies for brain and skull-based tumors. His lab has a long record of studying mouse models of brain tumors and he has developed a xenograft mouse model to study chordoma.

National Cancer Institute Comprehensive Cancer Center

The Johns Hopkins Comprehensive Brain Tumor Center is a National Cancer Institute (NCI) designated Comprehensive Cancer Center.
NCI designated Comprehensive Cancer Canter

 

Related Articles

The Hunt for a Brain Tumor Vaccine

Letting the Hounds Loose on Brain Tumors

Turning the Tables on Brain Tumors

Make a Gift - Find Out More

Out-of-State and International Patients - Find Out More

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System, All rights reserved.

Privacy Policy and Disclaimer